59
IntNSA 2016 October 6, 2016 1 Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA, CARN ASAM 2017 April 7, 2017

Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

  • Upload
    others

  • View
    6

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

IntNSA 2016 October 6, 2016 1

Anika Alvanzo, MD, MS, FASAM, FACP

Patti Burgee, MSN, MBA, CARN

ASAM 2017 April 7, 2017

Page 2: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

Anika Alvanzo, MD, MS, FASAM, FACPEmmi Solutions – Consulting Fee- Consultant

Indivior, Inc. – Consulting Fee - Consultant

ASAM 48th Annual Conference April 7, 2017

Disclosure Information

Page 3: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

ASAM 48th Annual Conference April 7, 2017

Disclosure Information

Patricia Burgee, MSN, MBA, CARNNo disclosures

Page 4: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

Determine necessary information to gather during the 3 phases of the substance use disorder (SUD) consultation

Discuss how to match patients to existing resources based upon their unique circumstances

Identify what aspects can be implemented in own clinical practice setting

Page 5: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

Introduction

Overview of the SUDS

Phase I: Pre-intervention

Phase II: Intervention

Phase III: Post-intervention

Case Studies

5

Page 6: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

Introduction and Overview

Page 7: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

Substance Use & Use Disorders

Prevalent

>22 million past year alcohol or drug use disorder

Costly

~$700 billion annual

Comorbidity

↑ Mortality

¼ deaths attributable to tobacco, alcohol or drugs

Page 8: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

8

Harmful Users~68 million

Abstainers/Low Risk Users

SUD~22.5 million

In Treatment

~ 4.3 million

Focus = Prevention

Focus = Early Intervention

Focus = Treatment

Focus = Retention, Sustained Recovery

Page 9: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

Up to 20% of general hospital wards patients have AUD

Up to 40% of ICUs patients have an AUD

12% had lifetime history of illicit drug use disorder

26% of hospitalized patients had current at-risk alcohol or drug use

Carlson, et al., 2012de Wit, et. al., 2010Katz, et. al., 2008Stein, et. al., 1996

Page 10: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

Hospitalization may be “teachable moment”

Brief interventions demonstrate reduction in alcohol consumption and death rates

Provider factors

under diagnose

under treat

lack confidence in treating

10

McQueen, et al., 2011Murphy, et al., 2009Moore, et al., 1989

Page 11: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

• First Step Day Hospital: 1997 – 2010

• Departments of Medicine and Psychiatry

• Ongoing medical care

• Wound care, IV antibiotics

• Behavioral health care

• Group and individual counseling

• Substance Use Disorders Consultation Service (SUDS): 2010 –present

11

Page 12: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

The Mission of the Johns Hopkins Hospital Substance Use DisordersConsultation Service (SUDS) is to improve the health and quality of lifeof patients with substance use disorders by providing non-judgmental,comprehensive, and patient-centered care and education. The SUDSperforms brief behavioral interventions and counseling to patients,facilitates linkage to hospital and community-based alcohol and drugtreatment programs, provides guidance on the clinical management ofpatients with substance use and associated consequences, and educatespatients, families, healthcare professionals and the community toprevent, identify, and treat persons living with addiction.

12

Page 13: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

13

Page 14: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

Medical Director (25% effort on K23)

Anika Alvanzo, MD, MS, FASAM, FACP

Nurse (1FTE)

Patricia Burgee, CARN, MSN, MBA

Senior Addictions Therapist (1FTE)

Diane Moses, MSW, M.Ed, LCAD-C

Peer Recovery Specialists (2FTE)

vacant

Page 15: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

Brief Interventions Motivational Interviewing

Linkage to Treatment Programs

Medical Management Withdrawal syndromes

Pain management in patients with opioid use disorders

Buprenorphine Bridge

Patient, Family and Clinician Education

Policy and Order Set Development

Page 16: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

16

0

20

40

60

80

100

120

140

160

180

FY 2012 (1430)

FY2013 (1441)

FY2014 (1823)

FY2015 (1606)

FY2016 (1380)

Page 17: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

January - December 2013 (N=1,648) January – December 2015 (N=1,449)

49.9 yrs old (SD 11.66)

61.8% male

73.9% Black, 22.9% White

81.6% uninsured or Medicaid*

(n = 1082)

62.1% alcohol

64.9% polysubstance use*

49.3 yrs old (SD 13.04)

61.2% male

65.4% Black, 28.5% White

Page 18: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

Relationship Building

Program Visits

Electronic Documentation

Qualified Service Organization Agreement (QSOA)

Clinical Database

Customer Survey

14-item survey using a 5-pt Likert scale (3.1 – 4.8)

Improving Clinical Care

Opioid and alcohol withdrawal protocols

18

Page 19: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

Demonstrating our value

Not a revenue generating service

Must be able to demonstrate cost savings

Readmission, Emergency Department visits, Length of Stay, expenditures

Treatment entry & engagement

Page 20: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

Multidisciplinary service

Counseling, treatment linkage with bridge, management of withdrawal and pain

~ 1400 referrals in last year

Customers overwhelmingly satisfied

Integral role in discharge planning

Page 21: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

Start building relationships now

Work out policies on information exchange

Standardize procedures and documents

Clinical database

Integration with Electronic Health Record

Determine outcomes and plan for measurement in advance

Page 22: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

Phase I: Pre-Intervention

22

Page 23: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

Reviewing the placed order

Who placed the order?

What services requested?

Where located?

Is patient aware order was placed?

23

Page 24: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

Chart Review History and Physical Admitting Diagnosis, History of Present Illness

Past Medical History Medical History

Psychiatric History

Substance Use History

Social History Family and Living Situation

Education and Occupation

24

Page 25: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

Chart Review

Demographics

Insurance

Medications

Withdrawal

Pain

Labs:

Toxicology, Blood alcohol level (BAL)

Infectious disease testing (HIV, Hep B/C, RPR)

25

Page 26: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

Other Sources

Prescription Drug Monitoring Program (PDMP)

Judiciary Case Search

Communication with Team

Anticipated Discharge Day

Pack your bag

What resource info do you need to bring?

26

Page 27: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

Phase II: The Intervention

March 23, 2017 27

Page 28: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

• SBIRT as done by SUDS Screening

- (Patients identified by referring provider)

- Ask permission to discuss substance use

- Goal: Patient engagement to capture honest report of current and past use

• Brief Intervention

- Goal: Identify the Stage of Change

- Goal: Reduce the risk of harm from continued substance use

• Referral to Treatment

- Goal: Determine which type of substance use treatment program, (if any) would be most effective and mutually agreeable

28

Page 29: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

• Establish a rapport- Non confrontational- Non judgmental- Information gathering- Exchange of conversation

- OARS - MI Skills

▪ Open-ended questions ▪ Affirmations▪ Reflection▪ Summarize

Page 30: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

Information Gathering • Literacy

• Working? Available hours for SUD

treatment

• Military- VA benefits

• Will religion have an impact?

• Living situation

• Legal history

Page 31: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

Information Gathering Substance Use History

Age of first use

How much, any history of overdose -

intentional?

Any periods of abstinence? Involuntary

abstinence (jail)? Use in jail?

Page 32: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

Information Gathering

Substance Use History History of treatment for substance use

disorder?

12-step or other support group experience?

Page 33: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

Information Gathering

Screening Tools AUDIT-C

ASSIST

Page 34: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

Information Gathering Barriers

Page 35: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

Intervention

Recommendations SUD program-all details

Medication regimen

Business card provided

Page 36: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

INDIRECT TIME DIRECT TIME

• Chart review • Brief Intervention

• Discharge planning with inpatient healthcare team member

• Counseling

• Request tablet education, i.e. Emmi smoking cessation module

• Discussion of Treatment Options

• Authorizations and/or phone calls to SUD programs -back and forth

• Education

• Complete online referral form(s) • Family intervention

• ROI – routing/faxing essential information

• Electronic Medical Record (EMR) charting

Page 37: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

Phase III: Post-Intervention

March 23, 2017 37

Page 38: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

History of present illness

Past medical and psych history

Family history of SUD

Extensive substance use history

Social history

Family and living situation

Education and employment

Legal history

Name of substance heroin

Route(s) of Use Intranasal/Insufflation - shares straws or work? No

History of Use: Started at about age 17 when "hanging with the wrong

people". Using off and on for 25 years with multiple

periods of extended abstinence, totaling about 12

years.

Current Use: Frequency: daily

Quantity: $30

Last Use: day prior to admission

History of overdose? No

Typical Substance Specific

Withdrawal Symptoms

***

DSM-5 Substance Use

Disorder Diagnostic Criteria

Inability to cut down or control use, Cravings, Role

failure, Continued use despite associated physical or

psychological problems, Tolerance and Withdrawal

Severe (over 6 criteria met)

Financing for Substance Use "money"; denies exchange of sex for drugs or money

Longest period of abstinence 6 years

Treatment Experience Multiple treatment admissions, medication assisted

treatment with methadone

Page 39: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

What elements go into our thought processes? What substance(s) is/are the patient using?

Does the patient require further detox?

Treatment history (have they failed outpatient treatment in past?)

ASAM criteria

Insurance coverage, private, commercial OR Medicaid

Language ability/cultural competence

Living situation

Transportation and Location How will the patient gain access to the treatment facility

Page 40: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

What elements go into our thought processes? What are the medical complications? Wound care

IV antibiotics

PICC line

Need to know referral resources in the community and surrounding community

Develop relationships, have inservices

Visit the programs

Page 41: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

Maryland Community Services Locator (MDCSL)

http://www.mdcsl.org/search.html

AA – on line- http://www.aa-intergroup.org/

NA – on line - http://www.12stepforums.net/na/

Smart Recovery- http://smartrecovery.org/ online

meetings CBT based

Page 42: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

Linkage for patient who is already in medication assisted treatment and requires increased level of care

Linkage for patient who is motivated and ready for buprenorphine medication assisted treatment

Involve SUD Medical Director

Page 43: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

Taper completion

Short-term script: bridge interval between discharge & intake appt

Patient education

Risks

Clinician education

Starting or increasing buprenorphine

Communication with treatment provider

43

Page 44: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

56 year old man

HCV, CAD, previous admission for heart block

Polysubstance use

Alcohol, cannabis, cocaine, heroin, tobacco

On methadone for last 2 weeks, up to 60mg

Admitted with bradycardia and heart block

Consult request: need to discontinue methadone secondary to heart block

44

Page 45: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

Methadone held: opioid withdrawal (w/d) and threatening to leave

Trial of 30mg of methadone for w/d

W/d symptoms controlled

Recurrent bradycardia and heart block

45

Page 46: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

What do you want to know?

Toxicology results

Name of program

Verify dose and when last received

What options has Cardiology given patient?

What does patient want to do?

On methadone with previous admission?

Is methadone associated with bradycardia and heart block?

46

Page 47: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

47

Methadone &

Permanent Pacemaker

No Pacemaker&

No Methadone

Decision = No Pacemaker

Page 48: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

Brief Intervention

Patient

Contact with methadone program

Family member

Post Intervention

Intake appointment for buprenorphine

Medication management

Discontinuation of methadone

Buprenorphine induction

48

Page 49: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

Buprenorphine bridge

1-day prescription

Prologue:

Reverted back to heart block

Permanent pacemaker placed

Discharged to buprenorphine program

Returned to methadone program about 1 week later

49

Page 50: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

• 28 year old man

• Endocarditis

• Polysubstance use

• Alcohol, cannabis, cocaine, heroin, tobacco

• Transferred to Johns Hopkins from outside hospital

• Consult request: Aftercare recommendations and pain management in the patient with an opioid use disorder

50

Page 51: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

What do you want to know?

Toxicology results

What happened at outside hospital?

What options has Cardiac Surgery given patient?

What does patient want to do?

51

Page 52: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

52

Full opioid agonists in

hospital and SNF

Buprenorphine and discharge to SNF

Decision = find a SNF able to administer Suboxone

Pain management

Page 53: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

What is going to be your approach with this patient?

53

Page 54: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

• Admitted to Skilled Nursing Facility for 4 weeks IV antibiotics

• Prologue:

• Mr. S. called SUDS three times while at SNF to give health updates

• SUDS kept him motivated for recovery

• Discharged from skilled nursing to an Intensive IOP with supportive housing

54

Page 55: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

63 year old man

Congestive heart failure

Atrial fibrillation, unspecified type

Long term use of anticoagulants

Polysubstance use

cannabis, tobacco

Admitted with shortness of breath- volume overload and pneumonia

Consult request: brief intervention and aftercare recommendation

55

Page 56: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

Intervention:

Easily engaged in superficial conversation

Using MI techniques, began to discuss cannabis use

Stage of Change: Precontemplative

Not ready to discontinue cannabis use

56

Page 57: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

Harm reduction

Reviewed potential harm reduction since he is not ready to stop cannabis use

Discussed smoking less and less often

Avoid persons who are using and/or supplying cannabis to him

Don’t inhale deeply or hold the smoke long

Don’t share blunts

Aftercare Recommendations

Although this may seem counterintuitive, harm reduction teaching will allow patient to think about ways to stay healthy

Continue to provide healthy heart and lung education

57

Page 58: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

58

Page 59: Anika Alvanzo, MD, MS, FASAM, FACP Patti Burgee, MSN, MBA

Anika Alvanzo, MD, MS, FASAM, FACP

[email protected]

Patti Burgee, MSN, MBA, CARN

[email protected]

59